$amod 2023 Q4 10-K

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.121M	$525.4K	$491.3K
YoY Change	315.33%	88.73%	44.69%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.115M	$1.411M	$4.448K
YoY Change	237.75%	329.89%	-98.86%
Operating Profit		-$575.4K	-$541.2K
YoY Change		75.29%	39.2%
Interest Expense	$157.2K	$391.5K	$209.6K
YoY Change	-96.09%	-86.78%	-93.5%
% of Operating Profit
Other Income/Expense, Net	$0.00	$399.5K	$327.0K
YoY Change		-86.51%	-89.85%
Pretax Income	-$957.4K	-$175.9K	-$214.3K
YoY Change	-125.94%	-106.68%	-107.56%
Income Tax	-$21.79K	$51.73K	$169.2K
% Of Pretax Income
Net Earnings	-$935.6K	-$227.6K	-$383.5K
YoY Change	-128.35%	-109.52%	-113.53%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.03	-$0.03	-$0.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$0.00	$144.6K
YoY Change	-100.0%	-100.0%	14.3%
Cash & Equivalents			$144.6K
Short-Term Investments
Other Short-Term Assets	$420.1K	$392.3K	$642.5K
YoY Change	5.01%	-23.97%	12.45%
Inventory
Prepaid Expenses	$105.6K	$86.17K	$85.00K
Receivables
Other Receivables	$195.0K
Total Short-Term Assets	$1.689M	$1.433M	$787.1K
YoY Change	213.49%	86.25%	12.78%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.66M	$10.43M	$29.84M
YoY Change	-95.63%	-95.7%	-87.63%
Other Assets
YoY Change
Total Long-Term Assets	$10.66M	$10.43M	$29.84M
YoY Change	-95.63%	-95.7%	-87.64%
TOTAL ASSETS
Total Short-Term Assets	$1.689M	$1.433M	$787.1K
Total Long-Term Assets	$10.66M	$10.43M	$29.84M
Total Assets	$12.35M	$11.86M	$30.63M
YoY Change	-94.95%	-95.12%	-87.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$89.31K	$51.06K	$91.06K
YoY Change	-30.68%	-68.03%	-3.79%
Accrued Expenses	$968.3K	$518.0K	$549.3K
YoY Change	1319.47%	659.34%	658.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.260M	$4.626M	$3.752M
YoY Change	485.09%	710.59%	1618.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.223M	$7.274M	$7.289M
YoY Change	-40.31%	-48.3%	-54.04%
Total Long-Term Liabilities	$7.223M	$7.274M	$7.289M
YoY Change	-40.31%	-48.3%	-54.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.260M	$4.626M	$3.752M
Total Long-Term Liabilities	$7.223M	$7.274M	$7.289M
Total Liabilities	$12.49M	$11.90M	$11.04M
YoY Change	-4.92%	-18.72%	-31.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.50M	-$11.26M	-$10.14M
YoY Change	-3.27%	-16.19%	-33.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.99M	-$11.26M	-$10.14M
YoY Change
Total Liabilities & Shareholders Equity	$12.35M	$11.86M	$30.63M
YoY Change	-94.95%	-95.12%	-87.35%

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$935.6K	-$227.6K	-$383.5K
YoY Change	-128.35%	-109.52%	-113.53%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$571.6K	-$1.407M	-$646.1K
YoY Change	614.51%	1684.82%	45.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$20.00K	$19.80M	-$1.960K
YoY Change		9518.38%
Cash From Investing Activities	-$20.00K	$19.80M	-$1.960K
YoY Change		9518.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	600.0K	-18.79M	-1.390K
YoY Change
NET CHANGE
Cash From Operating Activities	-571.6K	-1.407M	-646.1K
Cash From Investing Activities	-20.00K	19.80M	-1.960K
Cash From Financing Activities	600.0K	-18.79M	-1.390K
Net Change In Cash	8.390K	-396.0K	-649.5K
YoY Change	-110.49%	-411.74%	46.64%
FREE CASH FLOW
Cash From Operating Activities	-$571.6K	-$1.407M	-$646.1K
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35751	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12532018	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	615387	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	624584	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-651138	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21394576	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-2397590	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2418083	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	100000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	-86369	usd
CY2023	inaq	Adjustments To Additional Paid In Capital Fair Value Of Subscription Shares In Connection With Subscription Agreement AdjustmentsToAdditionalPaidInCapitalFairValueOfSubscriptionSharesInConnectionWithSubscriptionAgreement	391299	usd
CY2023	inaq	Adjustments Of Contribution Receivable From Sponsor AdjustmentsOfContributionReceivableFromSponsor	1074015	usd
CY2023	inaq	Excise Tax Payable Accumulated Deficit ExciseTaxPayableAccumulatedDeficit	-2348302	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-651138	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-10987144	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-651138	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	538200	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10711300	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	112054	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	3117552	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	3332546	usd
CY2023	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
CY2023	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability	86369	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-146658	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	156593	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-261651	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-509098	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-39524	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94503	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	900093	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	72253	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	300000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-367955	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	467991	usd
CY2022	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-8767	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	195000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2914349	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-827207	usd
CY2023	inaq	Proceeds From Sale Of Restricted Investment ProceedsFromSaleOfRestrictedInvestment	2497248	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40775
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3386030
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	333 East 91st Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10128
CY2023	dei	City Area Code CityAreaCode	(609)
CY2023	dei	Local Phone Number LocalPhoneNumber	751-9193
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	34404471	usd
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	171583	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	314482	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	105568	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	367219	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	1074015	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1689065	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	538802	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	10664690	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	244314622	usd
CY2023Q4	us-gaap	Assets Assets	12353755	usd
CY2022Q4	us-gaap	Assets Assets	244853424	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	89311	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128835	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	968309	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	68216	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	100036	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	467991	usd
CY2023Q4	inaq	Excise Tax Payable ExciseTaxPayable	2348302	usd
CY2022Q4	inaq	Franchise Tax Payable FranchiseTaxPayable	149041	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5260471	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	899083	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9935	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	156593	usd
CY2023Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2022Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	12000000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	623090	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	84890	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12493496	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13140566	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	10847403	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243597590	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	509211	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11496955	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11885332	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-10987144	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12353755	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	244853424	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2419328	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1305836	usd
CY2023	inaq	Franchise Tax Expense FranchiseTaxExpense	143200	usd
CY2022	inaq	Franchise Tax Expense FranchiseTaxExpense	205992	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2862528	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1511828	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	538200	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10711300	usd
CY2023	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability	86369	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	112054	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	3117552	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	3332546	usd
CY2023	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2826777	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14043846	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35751	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12532018	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	615387	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	624584	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-651138	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21394576	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-2397590	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2418083	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	100000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	-86369	usd
CY2023	inaq	Adjustments To Additional Paid In Capital Fair Value Of Subscription Shares In Connection With Subscription Agreement AdjustmentsToAdditionalPaidInCapitalFairValueOfSubscriptionSharesInConnectionWithSubscriptionAgreement	391299	usd
CY2023	inaq	Adjustments Of Contribution Receivable From Sponsor AdjustmentsOfContributionReceivableFromSponsor	1074015	usd
CY2023	inaq	Excise Tax Payable Accumulated Deficit ExciseTaxPayableAccumulatedDeficit	-2348302	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-651138	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-10987144	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11907434	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	538200	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10711300	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	112054	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	3117552	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	3332546	usd
CY2023	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability	86369	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-146658	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	156593	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-261651	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-509098	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-39524	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94503	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	900093	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	72253	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	300000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-367955	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	467991	usd
CY2023	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	149041	usd
CY2022	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-8767	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	195000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2914349	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-827207	usd
CY2023	inaq	Proceeds From Sale Of Restricted Investment ProceedsFromSaleOfRestrictedInvestment	2497248	usd
CY2022	inaq	Proceeds From Sale Of Restricted Investment ProceedsFromSaleOfRestrictedInvestment	205853	usd
CY2023	inaq	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption	234830236	usd
CY2023	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	560000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	236767484	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	205853	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	420000	usd
CY2023	inaq	Increase In Due To Investor IncreaseInDueToInvestor	-600000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	85000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	234830236	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-233710236	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	142899	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-706354	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	877937	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	314482	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2022Q4	us-gaap	Cash Cash	171583	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	314482	usd
CY2023	inaq	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	5126890	usd
CY2023	inaq	Value Of Excise Tax Liability ValueOfExciseTaxLiability	2348302	usd
CY2023	inaq	Capital Contribution From Sponsor CapitalContributionFromSponsor	1074015	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 1 - Description of Organization and Business Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has one subsidiary, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”), a direct wholly owned subsidiary of the Company incorporated in on October 10, 2023. As of December 31, 2023 the subsidiary had no activity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2023, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through December 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Company is unable to complete a Business Combination by June 7, 2024, which may be extended only by the vote of our stockholders to approve an amendment to our amended and restated certificate of incorporation (the “Combination Period”) the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Second Charter Amendment Proposal”), (iii) a proposal to amend the Charter to provide for the right of a holder of Class B common stock of the Company, par value $0.0001 per share (“Class B Common Stock”) to convert such shares into shares of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) on a one-for-one basis prior to the closing of a business combination at the election of the holder (the “Third Charter Amendment Proposal” and together with the First Charter Amendment Proposal and the Second Charter Amendment Proposal, the “Charter Amendment Proposals”) and (iv) a proposal to direct the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve each of the Charter Amendment Proposals. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 remained in the trust account and 2,848,607 shares of Class A Common Stock remained issued and outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 28, 2023, the board of directors of the Company approved a one-month extension of the date by which the Company has to consummate a business combination to May 7, 2023 and authorized management to deposit $80,000 into the Trust Account for such extension. Accordingly, management deposited $80,000 into the Trust Account and the date by which the Company has to consummate a business combination has been extended to May 7, 2023. On May 2, 2023, the board of directors of the Company approved an additional one-month extension to June 7, 2023 and deposited an additional $80,000 into the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase the Company’s Class A Common Stock from holders (other than the Company or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by the Company in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of the Company Class A Common Stock purchased in the Company’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On April 3, 2023, the Company entered into a Business Combination Agreement (“Avila BCA”) with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on April 4, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 18, 2022, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and that if the Form 10-K is not filed with the SEC by 2:30 p.m. Eastern Time on April 21, 2023, NYSE post the Company to the NYSE’s late filers list on the Profile, Data and News pages with respect to each of the Company’s securities (the “LF Designation”). Effective April 19, 2022, the Company filed the Form 10-K and that same day the Company received additional correspondence from the NYSE acknowledging that the filing had been made and cancelling its prior correspondence and stating that the LF Designation would not be posted on the Profile, Data and News pages with respect to each of the Company’s securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market (“Nasdaq”). In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 24, 2023, the Company received a notification from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250I(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q’s due date, or until November 20, 2023, to regain compliance. The Company subsequently filed the Form 10-Q for the quarter ended March 31, 2023 on June 2, 2023, regaining compliance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 10, 2023, the Company and Avila entered into a Letter Agreement providing for the mutual termination of the Avila BCA. The Letter Agreement provides for the mutual release of claims against the other party and also provides that Avila will pay to the Company $300,000 in partial reimbursement of expenses incurred by the Company in connection with the Avila BCA (the “Avila Payment”). The Avila Payment is due and payable as follows: 1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As approved by its stockholders at the annual meeting of stockholders held on September 6, 2023 (the “Annual Meeting”), the Company filed a Second Amendment (the “Second Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 6, 2023 to modify the terms and extend Combination Period by which the Company has to consummate an initial business combination (the “Business Combination”) from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 7, 2023, October 7, 2023, November 7, 2023, December 15, 2023, January 5, 2024, February 2, 2024, February 7, 2024, March 20, 2024 and May 6, 2024 the Company deposited $20,000 into the Trust Account on each date, to extend the Business Combination Period from September 7, 2023 to June 7, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective as of October 13, 2023, the Company, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”) and Alpha Modus, Corp., a Florida corporation (“Alpha Modus”), entered into a business combination agreement and plan of merger (the “AM BCA”) pursuant to which Merger Sub will merge with and into Alpha Modus with Alpha Modus as the surviving corporation and becoming a wholly owned subsidiary of the Company. The Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable the AM BCA, the Merger and the other transactions contemplated thereby (the “Proposed Transactions”). A copy of the AM BCA is filed as Exhibit 2.1 in the Current Report on Form 8-K, dated October 17, 2023. In connection with entering into the AM BCA, in October 2023, the Company formed IAC Merger Sub Inc., a Florida corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On December 28, 2023, the Company filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company held a meeting on March 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from March 7, 2023, monthly for up to six additional months at the election of the Company, ultimately until as late as September 7, 2023 (the “Extension”, and such extension date the “Extended Date”). In connection with the March 6, 2023 meeting, 21,151,393 shares of the Company’s common stock were redeemed with a total redemption payment of $215,621,387.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company held its annual meeting on September 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As a result, the Company booked a liability of $2,348,302 for the excise tax based on 1% of shares redeemed during the reporting period. For interim periods, an entity is not required to estimate future stock repurchases and stock issuances to measure its excise tax obligation. Rather, an entity can generally record the obligation on an as-incurred basis. In other words, the excise tax obligation recognized at the end of a quarterly financial reporting period is calculated as if the end of the quarterly period was the end of the annual period for which the excise tax obligation is payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the AM BCA, (i) in the event the business combination contemplated by the AM BCA occurs, then the surviving company shall pay the Company’s excise tax liability; (ii) if Alpha Modus does not obtain its shareholders approval of the business combination, or Alpha Modus breaches the AM BCA, then Alpha Modus will be responsible to pay the Company’s excise tax liability; and (iii) if an Alpha Modus material adverse effect occurs and the business combination does not close, or if Alpha Modus fails to close the business combination for any reason other than a material breach by the Company, then Alpha Modus will be responsible to pay the Company’s excise tax liability. In all other circumstances the Company will be responsible to pay the Company’s excise tax liability, except if the Company liquidates prior to December 31, 2023, in which event there will be no excise tax liability. The Company will not use any of the funds held in the Trust Account and any additional amounts deposited into the Trust Account, as well as any interest earned thereon, to pay for the Company’s excise tax liability. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax by the Company have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2023, the Israel-Hamas war commenced. As a result of the war, instability in the Middle East and various other regions of the world may occur and effect the world economy. Various nations, including the United States, as a reaction to the Israel-Hamas war have begun taking actions that may further affect the world economy. Such effects on the world economy are not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations and cash flows is also not determinable as of the date of these consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Emerging Growth Company</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Liquidity and Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2023, the Company had approximately $0 in its operating bank account available to pay operating expenses and working capital deficit of approximately $3,571,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding under any Working Capital Loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 30, 2023, the Company, Sponsor and Polar Multi-Strategy Master Fund (“Polar”), an investor, entered into an agreement (the “Subscription Agreement”) in which Polar has agreed to fund the Sponsor up to $1,000,000, pursuant to written draw down requests (a “Capital Call”), and the Sponsor will in turn loan such funds to the Company, to cover the Company’s working capital expenses (each a “Sponsor Loan”). For the year ended December 31, 2023, Polar funded Sponsor $600,000 under the Subscription Agreement and the Sponsor loaned the Company $600,000 from Polar.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until June 7, 2024 (extended monthly through extension payments), to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination by close of business on June 7, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 7, 2024.</p>
CY2023	inaq	Condition For Future Business Combination Number Of Businesses Minimum ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum	1	pure
CY2023	inaq	Investments Maximum Maturity Term InvestmentsMaximumMaturityTerm	P185D
CY2023Q4	inaq	Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount	0.80	pure
CY2023Q4	inaq	Percentage Of Shares Voted PercentageOfSharesVoted	0.65	pure
CY2023Q1	inaq	Condition For Future Business Combination Threshold Net Tangible Assets ConditionForFutureBusinessCombinationThresholdNetTangibleAssets	5000001	usd
CY2023	inaq	Avila Payment Description AvilaPaymentDescription	1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023	inaq	Number Of Shares Redemption In Exchange NumberOfSharesRedemptionInExchange	1847662	shares
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	19208848	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2022	inaq	Proceeds From Sale Of Restricted Investment ProceedsFromSaleOfRestrictedInvestment	205853	usd
CY2023	inaq	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption	234830236	usd
CY2023	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	560000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	236767484	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	205853	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	420000	usd
CY2023	inaq	Increase In Due To Investor IncreaseInDueToInvestor	-600000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	85000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	234830236	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-233710236	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	142899	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-706354	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	877937	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	314482	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	314482	usd
CY2023	inaq	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	5126890	usd
CY2023	inaq	Capital Contribution From Sponsor CapitalContributionFromSponsor	1074015	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 1 - Description of Organization and Business Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has one subsidiary, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”), a direct wholly owned subsidiary of the Company incorporated in on October 10, 2023. As of December 31, 2023 the subsidiary had no activity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2023, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through December 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Company is unable to complete a Business Combination by June 7, 2024, which may be extended only by the vote of our stockholders to approve an amendment to our amended and restated certificate of incorporation (the “Combination Period”) the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Second Charter Amendment Proposal”), (iii) a proposal to amend the Charter to provide for the right of a holder of Class B common stock of the Company, par value $0.0001 per share (“Class B Common Stock”) to convert such shares into shares of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) on a one-for-one basis prior to the closing of a business combination at the election of the holder (the “Third Charter Amendment Proposal” and together with the First Charter Amendment Proposal and the Second Charter Amendment Proposal, the “Charter Amendment Proposals”) and (iv) a proposal to direct the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve each of the Charter Amendment Proposals. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 remained in the trust account and 2,848,607 shares of Class A Common Stock remained issued and outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 28, 2023, the board of directors of the Company approved a one-month extension of the date by which the Company has to consummate a business combination to May 7, 2023 and authorized management to deposit $80,000 into the Trust Account for such extension. Accordingly, management deposited $80,000 into the Trust Account and the date by which the Company has to consummate a business combination has been extended to May 7, 2023. On May 2, 2023, the board of directors of the Company approved an additional one-month extension to June 7, 2023 and deposited an additional $80,000 into the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase the Company’s Class A Common Stock from holders (other than the Company or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by the Company in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of the Company Class A Common Stock purchased in the Company’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On April 3, 2023, the Company entered into a Business Combination Agreement (“Avila BCA”) with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on April 4, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 18, 2022, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and that if the Form 10-K is not filed with the SEC by 2:30 p.m. Eastern Time on April 21, 2023, NYSE post the Company to the NYSE’s late filers list on the Profile, Data and News pages with respect to each of the Company’s securities (the “LF Designation”). Effective April 19, 2022, the Company filed the Form 10-K and that same day the Company received additional correspondence from the NYSE acknowledging that the filing had been made and cancelling its prior correspondence and stating that the LF Designation would not be posted on the Profile, Data and News pages with respect to each of the Company’s securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market (“Nasdaq”). In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 24, 2023, the Company received a notification from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250I(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q’s due date, or until November 20, 2023, to regain compliance. The Company subsequently filed the Form 10-Q for the quarter ended March 31, 2023 on June 2, 2023, regaining compliance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 10, 2023, the Company and Avila entered into a Letter Agreement providing for the mutual termination of the Avila BCA. The Letter Agreement provides for the mutual release of claims against the other party and also provides that Avila will pay to the Company $300,000 in partial reimbursement of expenses incurred by the Company in connection with the Avila BCA (the “Avila Payment”). The Avila Payment is due and payable as follows: 1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As approved by its stockholders at the annual meeting of stockholders held on September 6, 2023 (the “Annual Meeting”), the Company filed a Second Amendment (the “Second Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 6, 2023 to modify the terms and extend Combination Period by which the Company has to consummate an initial business combination (the “Business Combination”) from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 7, 2023, October 7, 2023, November 7, 2023, December 15, 2023, January 5, 2024, February 2, 2024, February 7, 2024, March 20, 2024 and May 6, 2024 the Company deposited $20,000 into the Trust Account on each date, to extend the Business Combination Period from September 7, 2023 to June 7, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective as of October 13, 2023, the Company, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”) and Alpha Modus, Corp., a Florida corporation (“Alpha Modus”), entered into a business combination agreement and plan of merger (the “AM BCA”) pursuant to which Merger Sub will merge with and into Alpha Modus with Alpha Modus as the surviving corporation and becoming a wholly owned subsidiary of the Company. The Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable the AM BCA, the Merger and the other transactions contemplated thereby (the “Proposed Transactions”). A copy of the AM BCA is filed as Exhibit 2.1 in the Current Report on Form 8-K, dated October 17, 2023. In connection with entering into the AM BCA, in October 2023, the Company formed IAC Merger Sub Inc., a Florida corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On December 28, 2023, the Company filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company held a meeting on March 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from March 7, 2023, monthly for up to six additional months at the election of the Company, ultimately until as late as September 7, 2023 (the “Extension”, and such extension date the “Extended Date”). In connection with the March 6, 2023 meeting, 21,151,393 shares of the Company’s common stock were redeemed with a total redemption payment of $215,621,387.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company held its annual meeting on September 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As a result, the Company booked a liability of $2,348,302 for the excise tax based on 1% of shares redeemed during the reporting period. For interim periods, an entity is not required to estimate future stock repurchases and stock issuances to measure its excise tax obligation. Rather, an entity can generally record the obligation on an as-incurred basis. In other words, the excise tax obligation recognized at the end of a quarterly financial reporting period is calculated as if the end of the quarterly period was the end of the annual period for which the excise tax obligation is payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the AM BCA, (i) in the event the business combination contemplated by the AM BCA occurs, then the surviving company shall pay the Company’s excise tax liability; (ii) if Alpha Modus does not obtain its shareholders approval of the business combination, or Alpha Modus breaches the AM BCA, then Alpha Modus will be responsible to pay the Company’s excise tax liability; and (iii) if an Alpha Modus material adverse effect occurs and the business combination does not close, or if Alpha Modus fails to close the business combination for any reason other than a material breach by the Company, then Alpha Modus will be responsible to pay the Company’s excise tax liability. In all other circumstances the Company will be responsible to pay the Company’s excise tax liability, except if the Company liquidates prior to December 31, 2023, in which event there will be no excise tax liability. The Company will not use any of the funds held in the Trust Account and any additional amounts deposited into the Trust Account, as well as any interest earned thereon, to pay for the Company’s excise tax liability. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax by the Company have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2023, the Israel-Hamas war commenced. As a result of the war, instability in the Middle East and various other regions of the world may occur and effect the world economy. Various nations, including the United States, as a reaction to the Israel-Hamas war have begun taking actions that may further affect the world economy. Such effects on the world economy are not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations and cash flows is also not determinable as of the date of these consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Emerging Growth Company</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Liquidity and Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2023, the Company had approximately $0 in its operating bank account available to pay operating expenses and working capital deficit of approximately $3,571,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding under any Working Capital Loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 30, 2023, the Company, Sponsor and Polar Multi-Strategy Master Fund (“Polar”), an investor, entered into an agreement (the “Subscription Agreement”) in which Polar has agreed to fund the Sponsor up to $1,000,000, pursuant to written draw down requests (a “Capital Call”), and the Sponsor will in turn loan such funds to the Company, to cover the Company’s working capital expenses (each a “Sponsor Loan”). For the year ended December 31, 2023, Polar funded Sponsor $600,000 under the Subscription Agreement and the Sponsor loaned the Company $600,000 from Polar.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until June 7, 2024 (extended monthly through extension payments), to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination by close of business on June 7, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 7, 2024.</p>
CY2023	inaq	Condition For Future Business Combination Number Of Businesses Minimum ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum	1	pure
CY2023	inaq	Investments Maximum Maturity Term InvestmentsMaximumMaturityTerm	P185D
CY2023Q4	inaq	Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount	0.80	pure
CY2023Q4	inaq	Percentage Of Shares Voted PercentageOfSharesVoted	0.65	pure
CY2023Q1	inaq	Condition For Future Business Combination Threshold Net Tangible Assets ConditionForFutureBusinessCombinationThresholdNetTangibleAssets	5000001	usd
CY2023	inaq	Avila Payment Description AvilaPaymentDescription	1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023	inaq	Number Of Shares Redemption In Exchange NumberOfSharesRedemptionInExchange	1847662	shares
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	19208848	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q4	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21151393	shares
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	215621387	usd
CY2023Q3	inaq	Number Of Shares Redemption In Exchange NumberOfSharesRedemptionInExchange	1847662	shares
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2348302	usd
CY2023	inaq	Percentage Of Excise Tax Shares Redeemed During The Period PercentageOfExciseTaxSharesRedeemedDuringThePeriod	0.01	pure
CY2023Q4	inaq	Working Capital Deficit WorkingCapitalDeficit	3571000	usd
CY2023	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	163000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6000	usd
CY2023	us-gaap	Payments For Fees PaymentsForFees	600000	usd
CY2023	inaq	Sponsor Loan SponsorLoan	600000	usd
CY2023	us-gaap	Franchisor Costs FranchisorCosts	2703102	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1653743	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21151393	shares
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	215621387	usd
CY2023Q3	inaq	Number Of Shares Redemption In Exchange NumberOfSharesRedemptionInExchange	1847662	shares
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	19208848	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2348302	usd
CY2023	inaq	Percentage Of Excise Tax Shares Redeemed During The Period PercentageOfExciseTaxSharesRedeemedDuringThePeriod	0.01	pure
CY2023Q4	inaq	Working Capital Deficit WorkingCapitalDeficit	3571000	usd
CY2023	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	163000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6000	usd
CY2023	us-gaap	Payments For Fees PaymentsForFees	600000	usd
CY2023	inaq	Sponsor Loan SponsorLoan	600000	usd
CY2023	us-gaap	Franchisor Costs FranchisorCosts	2703102	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1653743	usd
CY2023	inaq	Withdrawn From Trust Account And Tax Accured WithdrawnFromTrustAccountAndTaxAccured	1049359	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	628758	usd
CY2023Q3	inaq	Withdrawal Amount WithdrawalAmount	1049359	usd
CY2023Q3	inaq	Due From Sponsor DueFromSponsor	994950	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	314482	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2023	inaq	Withdrawn From Trust Account And Tax Accured WithdrawnFromTrustAccountAndTaxAccured	1049359	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	628758	usd
CY2023Q3	inaq	Withdrawal Amount WithdrawalAmount	1049359	usd
CY2023Q3	inaq	Due From Sponsor DueFromSponsor	994950	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	314482	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i> </i></b></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i> </i></b></p>
CY2023	inaq	Investment Securitie Maturity Period InvestmentSecuritieMaturityPeriod	P185D
CY2023	inaq	Investment Securitie Maturity Period InvestmentSecuritieMaturityPeriod	P185D
CY2023Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	600000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	279245	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	600000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	279245	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	156593	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	156593	usd
CY2023	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1:1.1162791 stock split of Class B common stock
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023	inaq	Class Of Warrant Or Right Black Out Trading Period After Completion Of Business Combination ClassOfWarrantOrRightBlackOutTradingPeriodAfterCompletionOfBusinessCombination	P30D
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	180000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	180000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	480000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2023Q4	inaq	Sponsor Advance SponsorAdvance	420000	usd
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	On July 20, 2023 and August 7, 2023, a total of $891,000 was transferred to the Sponsor from the operating bank account, of which a total of $616,000 was paid back on October 10, 2023, October 11, 2023 and December 13, 2023. Additionally, during the year ended December 31, 2023 the Sponsor paid operating expenses on behalf of the Company with a total value of $80,000 which has been netted against the amount owed.
CY2023Q1	inaq	Waiver Of Underwriting Commissions WaiverOfUnderwritingCommissions	5400000	usd
CY2023Q1	inaq	Deferred Underwriting Commissions DeferredUnderwritingCommissions	8400000	usd
CY2023Q1	inaq	Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable GainLossOnForgivenessOfDeferredUnderwritingFeesPayable	273110	usd
CY2023Q1	inaq	Reminder Of Deferred Underwriting Commissions ReminderOfDeferredUnderwritingCommissions	3000000	usd
CY2023Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2022Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	12000000	usd
CY2023Q3	inaq	Reimbursement Of Expenses ReimbursementOfExpenses	300000	usd
CY2023	inaq	Avila Payment Description AvilaPaymentDescription	1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023	us-gaap	Payments For Fees PaymentsForFees	600000	usd
CY2023	inaq	Sponsor Loaned SponsorLoaned	325000	usd
CY2023Q4	inaq	Issuance Share issuanceShare	1	shares
CY2023Q4	us-gaap	Capital Units Outstanding CapitalUnitsOutstanding	10	shares
CY2023Q3	inaq	Reasonable Attorneys Fees ReasonableAttorneysFees	5000	usd
CY2023	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1:1.1162791 stock split of Class B common stock
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023	inaq	Class Of Warrant Or Right Black Out Trading Period After Completion Of Business Combination ClassOfWarrantOrRightBlackOutTradingPeriodAfterCompletionOfBusinessCombination	P30D
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	180000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	180000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	480000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2023Q4	inaq	Sponsor Advance SponsorAdvance	420000	usd
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	On July 20, 2023 and August 7, 2023, a total of $891,000 was transferred to the Sponsor from the operating bank account, of which a total of $616,000 was paid back on October 10, 2023, October 11, 2023 and December 13, 2023. Additionally, during the year ended December 31, 2023 the Sponsor paid operating expenses on behalf of the Company with a total value of $80,000 which has been netted against the amount owed.
CY2023Q1	inaq	Waiver Of Underwriting Commissions WaiverOfUnderwritingCommissions	5400000	usd
CY2023Q1	inaq	Deferred Underwriting Commissions DeferredUnderwritingCommissions	8400000	usd
CY2023Q1	inaq	Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable GainLossOnForgivenessOfDeferredUnderwritingFeesPayable	273110	usd
CY2023Q1	inaq	Reminder Of Deferred Underwriting Commissions ReminderOfDeferredUnderwritingCommissions	3000000	usd
CY2023Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2023Q3	inaq	Reimbursement Of Expenses ReimbursementOfExpenses	300000	usd
CY2023	inaq	Avila Payment Description AvilaPaymentDescription	1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023	inaq	Sponsor Loaned SponsorLoaned	325000	usd
CY2023Q4	inaq	Issuance Share issuanceShare	1	shares
CY2023Q4	us-gaap	Capital Units Outstanding CapitalUnitsOutstanding	10	shares
CY2023Q3	inaq	Reasonable Attorneys Fees ReasonableAttorneysFees	5000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	inaq	Share Redemption Trigger Price ShareRedemptionTriggerPrice	18
CY2023Q4	inaq	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2023	inaq	Class Of Warrant Or Right Redemption Of Warrants Or Rights ClassOfWarrantOrRightRedemptionOfWarrantsOrRights	P30D
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	762045	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-673365	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-85640	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-526707	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-242233	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	615387	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	369323	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	896030	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	369323	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	896030	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	369323	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	156593	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	156593	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	896030	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	369323	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-526707	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	inaq	Share Redemption Trigger Price ShareRedemptionTriggerPrice	18
CY2023Q4	inaq	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2023	inaq	Class Of Warrant Or Right Redemption Of Warrants Or Rights ClassOfWarrantOrRightRedemptionOfWarrantsOrRights	P30D
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	762045	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	467991	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-673365	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-85640	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-526707	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-242233	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	615387	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	624584	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	896030	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	369323	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	896030	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	896030	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	369323	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	156593	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	9935	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	156593	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	896030	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-526707	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants	0	pure
CY2022	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants	0	pure
CY2023	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-3.161	pure
CY2022	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-0.179	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.507	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.036	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2023	inaq	Effective Income Tax Rate True Up Startup Organization Costs EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts	-0.071	pure
CY2022	inaq	Effective Income Tax Rate True Up Startup Organization Costs EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-14.662	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.019	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	17.213	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.05	pure
CY2023	us-gaap	Franchisor Costs FranchisorCosts	2703102	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1653743	usd
CY2023	inaq	Withdrawn From Trust Account And Tax Accured WithdrawnFromTrustAccountAndTaxAccured	1049359	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1415512	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4448	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-242233	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants	0	pure
CY2022	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants	0	pure
CY2023	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-3.161	pure
CY2022	inaq	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-0.179	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.507	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.036	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2023	inaq	Effective Income Tax Rate True Up Startup Organization Costs EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts	-0.071	pure
CY2022	inaq	Effective Income Tax Rate True Up Startup Organization Costs EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-14.662	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	17.213	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.05	pure
CY2023	us-gaap	Franchisor Costs FranchisorCosts	2703102	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1653743	usd
CY2023	inaq	Withdrawn From Trust Account And Tax Accured WithdrawnFromTrustAccountAndTaxAccured	1049359	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1415512	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1411063	usd
CY2023Q3	inaq	Transfer From Operating Account To Sponsor TransferFromOperatingAccountToSponsor	480000	usd
CY2023Q4	inaq	Sponsor Transferred To The Company SponsorTransferredToTheCompany	891000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	628758	usd
CY2023Q3	inaq	Withdrawal Amount WithdrawalAmount	1049359	usd
CY2023Q3	inaq	Due From Sponsor DueFromSponsor	994950	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	2497250	usd
	inaq	Installment Payments InstallmentPayments	1130000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	317900	usd
	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	3049360	usd
CY2024Q1	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	1049360	usd
CY2024Q1	inaq	Additional Amount In Trust Account AdditionalAmountInTrustAccount	36285.07	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	132500	usd
CY2023	inaq	Service Fees ServiceFees	7500	usd
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2022Q4	inaq	Excise Tax Payable ExciseTaxPayable		usd
CY2023Q4	inaq	Franchise Tax Payable FranchiseTaxPayable		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability		usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1411063	usd
CY2023Q3	inaq	Transfer From Operating Account To Sponsor TransferFromOperatingAccountToSponsor	480000	usd
CY2023Q3	inaq	Transfer From Operating Account To Sponsor TransferFromOperatingAccountToSponsor	411000	usd
CY2023Q4	inaq	Sponsor Transferred To The Company SponsorTransferredToTheCompany	891000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	628758	usd
CY2023Q3	inaq	Withdrawal Amount WithdrawalAmount	1049359	usd
CY2023Q3	inaq	Due From Sponsor DueFromSponsor	994950	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
CY2024Q1	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	20000	usd
	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	2497250	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1447900	usd
	inaq	Installment Payments InstallmentPayments	1130000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	317900	usd
	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	3049360	usd
CY2024Q1	inaq	Amount Withdrew From Trust Account AmountWithdrewFromTrustAccount	1049360	usd
CY2024Q1	inaq	Additional Amount In Trust Account AdditionalAmountInTrustAccount	36285.07	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	132500	usd
CY2023	inaq	Service Fees ServiceFees	7500	usd
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2022Q4	inaq	Excise Tax Payable ExciseTaxPayable		usd
CY2023Q4	inaq	Franchise Tax Payable FranchiseTaxPayable		usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-35751

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

12532018

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

615387

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

624584

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-651138

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

-21394576

usd

CY2022

us-gaap

Temporary Equity Accretion To Redemption Value Adjustment

TemporaryEquityAccretionToRedemptionValueAdjustment

-2397590

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

-11884732

usd

CY2023

us-gaap

Temporary Equity Accretion To Redemption Value Adjustment

TemporaryEquityAccretionToRedemptionValueAdjustment

2418083

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Other

AdjustmentsToAdditionalPaidInCapitalOther

100000

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Mark To Market

AdjustmentsToAdditionalPaidInCapitalMarkToMarket

-86369

usd

CY2023

inaq

Adjustments To Additional Paid In Capital Fair Value Of Subscription Shares In Connection With Subscription Agreement

AdjustmentsToAdditionalPaidInCapitalFairValueOfSubscriptionSharesInConnectionWithSubscriptionAgreement

391299

usd

CY2023

inaq

Adjustments Of Contribution Receivable From Sponsor

AdjustmentsOfContributionReceivableFromSponsor

1074015

usd

CY2023

inaq

Excise Tax Payable Accumulated Deficit

ExciseTaxPayableAccumulatedDeficit

-2348302

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-651138

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

-10987144

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-651138

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2023

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

538200

usd

CY2022

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

-10711300

usd

CY2023

us-gaap

Interest Expense Debt

InterestExpenseDebt

112054

usd

CY2023

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3117552

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3332546

usd

CY2023

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

273110

usd

CY2023

inaq

Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability

GainLossChangeInFairValueOfForwardPurchaseAgreementLiability

86369

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-146658

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

156593

usd

CY2023

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

-261651

usd

CY2022

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

-509098

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-39524

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

94503

usd

CY2023

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

900093

usd

CY2022

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

72253

usd

CY2023

us-gaap

Increase Decrease In Due To Related Parties

IncreaseDecreaseInDueToRelatedParties

300000

usd

CY2023

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-367955

usd

CY2022

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

467991

usd

CY2022

inaq

Increase Decrease In Franchise Tax Payable

IncreaseDecreaseInFranchiseTaxPayable

-8767

usd

CY2023

us-gaap

Increase Decrease In Due From Related Parties

IncreaseDecreaseInDueFromRelatedParties

195000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-2914349

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-827207

usd

CY2023

inaq

Proceeds From Sale Of Restricted Investment

ProceedsFromSaleOfRestrictedInvestment

2497248

usd

CY2023

dei

Document Type

DocumentType

10-K

CY2023

dei

Document Annual Report

DocumentAnnualReport

true

CY2023

dei

Document Period End Date

DocumentPeriodEndDate

2023-12-31

CY2023

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2023

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2023

CY2023

dei

Document Transition Report

DocumentTransitionReport

false

CY2023

dei

Entity File Number

EntityFileNumber

001-40775

CY2023

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2023

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

86-3386030

CY2023

dei

Entity Address Address Line1

EntityAddressAddressLine1

333 East 91st Street

CY2023

dei

Entity Address City Or Town

EntityAddressCityOrTown

New York

CY2023

dei

Entity Address State Or Province

EntityAddressStateOrProvince

NY

CY2023

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

10128

CY2023

dei

City Area Code

CityAreaCode

(609)

CY2023

dei

Local Phone Number

LocalPhoneNumber

751-9193

CY2023

dei

Entity Filer Category

EntityFilerCategory

Non-accelerated Filer

CY2023

dei

Entity Small Business

EntitySmallBusiness

true

CY2023

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

true

CY2023

dei

Entity Ex Transition Period

EntityExTransitionPeriod

false

CY2023

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

false

CY2023

dei

Document Fin Stmt Error Correction Flag

DocumentFinStmtErrorCorrectionFlag

false

CY2023

dei

Entity Shell Company

EntityShellCompany

true

CY2023Q2

dei

Entity Public Float

EntityPublicFloat

34404471

usd

CY2023

ecd

Non Rule10b51 Arr Trmntd Flag

NonRule10b51ArrTrmntdFlag

false

CY2023

ecd

Rule10b51 Arr Trmntd Flag

Rule10b51ArrTrmntdFlag

false

CY2023

ecd

Non Rule10b51 Arr Adopted Flag

NonRule10b51ArrAdoptedFlag

false

CY2023

ecd

Rule10b51 Arr Adopted Flag

Rule10b51ArrAdoptedFlag

false

CY2023

dei

Auditor Name

AuditorName

WithumSmith+Brown, PC

CY2023

dei

Auditor Location

AuditorLocation

New York, New York

CY2023

dei

Auditor Firm

AuditorFirmId

100

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

171583

usd

CY2023Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

314482

usd

CY2023Q4

us-gaap

Prepaid Expense Current

PrepaidExpenseCurrent

105568

usd

CY2022Q4

us-gaap

Prepaid Expense Current

PrepaidExpenseCurrent

367219

usd

CY2023Q4

us-gaap

Other Receivables

OtherReceivables

1074015

usd

CY2023Q4

us-gaap

Assets Current

AssetsCurrent

1689065

usd

CY2022Q4

us-gaap

Assets Current

AssetsCurrent

538802

usd

CY2023Q4

us-gaap

Assets Held In Trust Noncurrent

AssetsHeldInTrustNoncurrent

10664690

usd

CY2022Q4

us-gaap

Assets Held In Trust Noncurrent

AssetsHeldInTrustNoncurrent

244314622

usd

CY2023Q4

us-gaap

Assets

12353755

usd

CY2022Q4

us-gaap

Assets

244853424

usd

CY2023Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

89311

usd

CY2022Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

128835

usd

CY2023Q4

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

968309

usd

CY2022Q4

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

68216

usd

CY2023Q4

us-gaap

Taxes Payable Current

TaxesPayableCurrent

100036

usd

CY2022Q4

us-gaap

Taxes Payable Current

TaxesPayableCurrent

467991

usd

CY2023Q4

inaq

Excise Tax Payable

ExciseTaxPayable

2348302

usd

CY2022Q4

inaq

Franchise Tax Payable

FranchiseTaxPayable

149041

usd

CY2023Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

5260471

usd

CY2022Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

899083

usd

CY2023Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

9935

usd

CY2022Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

156593

usd

CY2023Q4

inaq

Deferred Underwriting Commissions Noncurrent

DeferredUnderwritingCommissionsNoncurrent

6600000

usd

CY2022Q4

inaq

Deferred Underwriting Commissions Noncurrent

DeferredUnderwritingCommissionsNoncurrent

12000000

usd

CY2023Q4

us-gaap

Derivative Liabilities Noncurrent

DerivativeLiabilitiesNoncurrent

623090

usd

CY2022Q4

us-gaap

Derivative Liabilities Noncurrent

DerivativeLiabilitiesNoncurrent

84890

usd

CY2023Q4

us-gaap

Liabilities

12493496

usd

CY2022Q4

us-gaap

Liabilities

13140566

usd

CY2023Q4

us-gaap

Temporary Equity Carrying Amount Attributable To Parent

TemporaryEquityCarryingAmountAttributableToParent

10847403

usd

CY2022Q4

us-gaap

Temporary Equity Carrying Amount Attributable To Parent

TemporaryEquityCarryingAmountAttributableToParent

243597590

usd

CY2023Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2022Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

1000000

shares

CY2022Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

1000000

shares

CY2023Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

509211

usd

CY2023Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-11496955

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-11885332

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

-10987144

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

-11884732

usd

CY2023Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

12353755

usd

CY2022Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

244853424

usd

CY2023

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

2419328

usd

CY2022

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

1305836

usd

CY2023

inaq

Franchise Tax Expense

FranchiseTaxExpense

143200

usd

CY2022

inaq

Franchise Tax Expense

FranchiseTaxExpense

205992

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

-2862528

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

-1511828

usd

CY2023

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

538200

usd

CY2022

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

-10711300

usd

CY2023

inaq

Change In Fair Value Of Forward Purchases Agreement Liability

ChangeInFairValueOfForwardPurchasesAgreementLiability

86369

usd

CY2023

us-gaap

Interest Expense Debt

InterestExpenseDebt

112054

usd

CY2023

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3117552

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3332546

usd

CY2023

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

273110

usd

CY2023

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

2826777

usd

CY2022

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

14043846

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-35751

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

12532018

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

615387

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

624584

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-651138

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

-21394576

usd

CY2022

us-gaap

Temporary Equity Accretion To Redemption Value Adjustment

TemporaryEquityAccretionToRedemptionValueAdjustment

-2397590

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

-11884732

usd

CY2023

us-gaap

Temporary Equity Accretion To Redemption Value Adjustment

TemporaryEquityAccretionToRedemptionValueAdjustment

2418083

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Other

AdjustmentsToAdditionalPaidInCapitalOther

100000

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Mark To Market

AdjustmentsToAdditionalPaidInCapitalMarkToMarket

-86369

usd

CY2023

inaq

Adjustments To Additional Paid In Capital Fair Value Of Subscription Shares In Connection With Subscription Agreement

AdjustmentsToAdditionalPaidInCapitalFairValueOfSubscriptionSharesInConnectionWithSubscriptionAgreement

391299

usd

CY2023

inaq

Adjustments Of Contribution Receivable From Sponsor

AdjustmentsOfContributionReceivableFromSponsor

1074015

usd

CY2023

inaq

Excise Tax Payable Accumulated Deficit

ExciseTaxPayableAccumulatedDeficit

-2348302

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-651138

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

-10987144

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

11907434

usd

CY2023

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

538200

usd

CY2022

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

-10711300

usd

CY2023

us-gaap

Interest Expense Debt

InterestExpenseDebt

112054

usd

CY2023

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3117552

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

3332546

usd

CY2023

inaq

Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability

GainLossChangeInFairValueOfForwardPurchaseAgreementLiability

86369

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-146658

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

156593

usd

CY2023

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

-261651

usd

CY2022

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

-509098

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-39524

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

94503

usd

CY2023

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

900093

usd

CY2022

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

72253

usd

CY2023

us-gaap

Increase Decrease In Due To Related Parties

IncreaseDecreaseInDueToRelatedParties

300000

usd

CY2023

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-367955

usd

CY2022

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

467991

usd

CY2023

inaq

Increase Decrease In Franchise Tax Payable

IncreaseDecreaseInFranchiseTaxPayable

149041

usd

CY2022

inaq

Increase Decrease In Franchise Tax Payable

IncreaseDecreaseInFranchiseTaxPayable

-8767

usd

CY2023

us-gaap

Increase Decrease In Due From Related Parties

IncreaseDecreaseInDueFromRelatedParties

195000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-2914349

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-827207

usd

CY2023

inaq

Proceeds From Sale Of Restricted Investment

ProceedsFromSaleOfRestrictedInvestment

2497248

usd

CY2022

inaq

Proceeds From Sale Of Restricted Investment

ProceedsFromSaleOfRestrictedInvestment

205853

usd

CY2023

inaq

Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption

ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption

234830236

usd

CY2023

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

560000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

236767484

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

205853

usd

CY2023

us-gaap

Proceeds From Related Party Debt

ProceedsFromRelatedPartyDebt

100000

usd

CY2023

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

420000

usd

CY2023

inaq

Increase In Due To Investor

IncreaseInDueToInvestor

-600000

usd

CY2022

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

85000

usd

CY2023

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

234830236

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-233710236

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-85000

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

142899

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

-706354

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

171583

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

877937

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

314482

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

171583

usd

CY2022Q4

us-gaap

Cash

171583

usd

CY2023Q4

us-gaap

Restricted Cash

RestrictedCash

314482

usd

CY2023

inaq

Forgiveness Of Deferred Underwriting Fee Payable

ForgivenessOfDeferredUnderwritingFeePayable

5126890

usd

CY2023

inaq

Value Of Excise Tax Liability

ValueOfExciseTaxLiability

2348302

usd

CY2023

inaq

Capital Contribution From Sponsor

CapitalContributionFromSponsor

1074015

usd

CY2023

us-gaap

Nature Of Operations

NatureOfOperations

Note 1 - Description of Organization and Business Operations Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. The Company has one subsidiary, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”), a direct wholly owned subsidiary of the Company incorporated in on October 10, 2023. As of December 31, 2023 the subsidiary had no activity. As of December 31, 2023, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through December 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company is unable to complete a Business Combination by June 7, 2024, which may be extended only by the vote of our stockholders to approve an amendment to our amended and restated certificate of incorporation (the “Combination Period”) the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Second Charter Amendment Proposal”), (iii) a proposal to amend the Charter to provide for the right of a holder of Class B common stock of the Company, par value $0.0001 per share (“Class B Common Stock”) to convert such shares into shares of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) on a one-for-one basis prior to the closing of a business combination at the election of the holder (the “Third Charter Amendment Proposal” and together with the First Charter Amendment Proposal and the Second Charter Amendment Proposal, the “Charter Amendment Proposals”) and (iv) a proposal to direct the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve each of the Charter Amendment Proposals. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 remained in the trust account and 2,848,607 shares of Class A Common Stock remained issued and outstanding. On March 28, 2023, the board of directors of the Company approved a one-month extension of the date by which the Company has to consummate a business combination to May 7, 2023 and authorized management to deposit $80,000 into the Trust Account for such extension. Accordingly, management deposited $80,000 into the Trust Account and the date by which the Company has to consummate a business combination has been extended to May 7, 2023. On May 2, 2023, the board of directors of the Company approved an additional one-month extension to June 7, 2023 and deposited an additional $80,000 into the Trust Account. On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase the Company’s Class A Common Stock from holders (other than the Company or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by the Company in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of the Company Class A Common Stock purchased in the Company’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares). On April 3, 2023, the Company entered into a Business Combination Agreement (“Avila BCA”) with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on April 4, 2023. On April 18, 2022, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and that if the Form 10-K is not filed with the SEC by 2:30 p.m. Eastern Time on April 21, 2023, NYSE post the Company to the NYSE’s late filers list on the Profile, Data and News pages with respect to each of the Company’s securities (the “LF Designation”). Effective April 19, 2022, the Company filed the Form 10-K and that same day the Company received additional correspondence from the NYSE acknowledging that the filing had been made and cancelling its prior correspondence and stating that the LF Designation would not be posted on the Profile, Data and News pages with respect to each of the Company’s securities. On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market (“Nasdaq”). In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market. On May 24, 2023, the Company received a notification from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250I(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q’s due date, or until November 20, 2023, to regain compliance. The Company subsequently filed the Form 10-Q for the quarter ended March 31, 2023 on June 2, 2023, regaining compliance. On August 10, 2023, the Company and Avila entered into a Letter Agreement providing for the mutual termination of the Avila BCA. The Letter Agreement provides for the mutual release of claims against the other party and also provides that Avila will pay to the Company $300,000 in partial reimbursement of expenses incurred by the Company in connection with the Avila BCA (the “Avila Payment”). The Avila Payment is due and payable as follows: 1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024. On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note. As approved by its stockholders at the annual meeting of stockholders held on September 6, 2023 (the “Annual Meeting”), the Company filed a Second Amendment (the “Second Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 6, 2023 to modify the terms and extend Combination Period by which the Company has to consummate an initial business combination (the “Business Combination”) from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. On September 7, 2023, October 7, 2023, November 7, 2023, December 15, 2023, January 5, 2024, February 2, 2024, February 7, 2024, March 20, 2024 and May 6, 2024 the Company deposited $20,000 into the Trust Account on each date, to extend the Business Combination Period from September 7, 2023 to June 7, 2024. Effective as of October 13, 2023, the Company, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”) and Alpha Modus, Corp., a Florida corporation (“Alpha Modus”), entered into a business combination agreement and plan of merger (the “AM BCA”) pursuant to which Merger Sub will merge with and into Alpha Modus with Alpha Modus as the surviving corporation and becoming a wholly owned subsidiary of the Company. The Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable the AM BCA, the Merger and the other transactions contemplated thereby (the “Proposed Transactions”). A copy of the AM BCA is filed as Exhibit 2.1 in the Current Report on Form 8-K, dated October 17, 2023. In connection with entering into the AM BCA, in October 2023, the Company formed IAC Merger Sub Inc., a Florida corporation. On December 28, 2023, the Company filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”). The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these consolidated financial statements. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The Company held a meeting on March 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from March 7, 2023, monthly for up to six additional months at the election of the Company, ultimately until as late as September 7, 2023 (the “Extension”, and such extension date the “Extended Date”). In connection with the March 6, 2023 meeting, 21,151,393 shares of the Company’s common stock were redeemed with a total redemption payment of $215,621,387. The Company held its annual meeting on September 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. As a result, the Company booked a liability of $2,348,302 for the excise tax based on 1% of shares redeemed during the reporting period. For interim periods, an entity is not required to estimate future stock repurchases and stock issuances to measure its excise tax obligation. Rather, an entity can generally record the obligation on an as-incurred basis. In other words, the excise tax obligation recognized at the end of a quarterly financial reporting period is calculated as if the end of the quarterly period was the end of the annual period for which the excise tax obligation is payable. Pursuant to the AM BCA, (i) in the event the business combination contemplated by the AM BCA occurs, then the surviving company shall pay the Company’s excise tax liability; (ii) if Alpha Modus does not obtain its shareholders approval of the business combination, or Alpha Modus breaches the AM BCA, then Alpha Modus will be responsible to pay the Company’s excise tax liability; and (iii) if an Alpha Modus material adverse effect occurs and the business combination does not close, or if Alpha Modus fails to close the business combination for any reason other than a material breach by the Company, then Alpha Modus will be responsible to pay the Company’s excise tax liability. In all other circumstances the Company will be responsible to pay the Company’s excise tax liability, except if the Company liquidates prior to December 31, 2023, in which event there will be no excise tax liability. The Company will not use any of the funds held in the Trust Account and any additional amounts deposited into the Trust Account, as well as any interest earned thereon, to pay for the Company’s excise tax liability. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax by the Company have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. In October 2023, the Israel-Hamas war commenced. As a result of the war, instability in the Middle East and various other regions of the world may occur and effect the world economy. Various nations, including the United States, as a reaction to the Israel-Hamas war have begun taking actions that may further affect the world economy. Such effects on the world economy are not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations and cash flows is also not determinable as of the date of these consolidated financial statements. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Liquidity and Going Concern As of December 31, 2023, the Company had approximately $0 in its operating bank account available to pay operating expenses and working capital deficit of approximately $3,571,000. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding under any Working Capital Loans. On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note. On August 30, 2023, the Company, Sponsor and Polar Multi-Strategy Master Fund (“Polar”), an investor, entered into an agreement (the “Subscription Agreement”) in which Polar has agreed to fund the Sponsor up to $1,000,000, pursuant to written draw down requests (a “Capital Call”), and the Sponsor will in turn loan such funds to the Company, to cover the Company’s working capital expenses (each a “Sponsor Loan”). For the year ended December 31, 2023, Polar funded Sponsor $600,000 under the Subscription Agreement and the Sponsor loaned the Company $600,000 from Polar. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until June 7, 2024 (extended monthly through extension payments), to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination by close of business on June 7, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 7, 2024.

CY2023

inaq

Condition For Future Business Combination Number Of Businesses Minimum

ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum

1

pure

CY2023

inaq

Investments Maximum Maturity Term

InvestmentsMaximumMaturityTerm

P185D

CY2023Q4

inaq

Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account

PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount

0.80

pure

CY2023Q4

inaq

Percentage Of Shares Voted

PercentageOfSharesVoted

0.65

pure

CY2023Q1

inaq

Condition For Future Business Combination Threshold Net Tangible Assets

ConditionForFutureBusinessCombinationThresholdNetTangibleAssets

5000001

usd

CY2023

inaq

Avila Payment Description

AvilaPaymentDescription

1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.

CY2023

inaq

Number Of Shares Redemption In Exchange

NumberOfSharesRedemptionInExchange

1847662

shares

CY2023

us-gaap

Stock Redeemed Or Called During Period Value

StockRedeemedOrCalledDuringPeriodValue

19208848

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2022

inaq

Proceeds From Sale Of Restricted Investment

ProceedsFromSaleOfRestrictedInvestment

205853

usd

CY2023

inaq

Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption

ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption

234830236

usd

CY2023

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

560000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

236767484

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

205853

usd

CY2023

us-gaap

Proceeds From Related Party Debt

ProceedsFromRelatedPartyDebt

100000

usd

CY2023

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

420000

usd

CY2023

inaq

Increase In Due To Investor

IncreaseInDueToInvestor

-600000

usd

CY2022

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

85000

usd

CY2023

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

234830236

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-233710236

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-85000

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

142899

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

-706354

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

171583

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

877937

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

314482

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

171583

usd

CY2023Q4

us-gaap

Restricted Cash

RestrictedCash

314482

usd

CY2023

inaq

Forgiveness Of Deferred Underwriting Fee Payable

ForgivenessOfDeferredUnderwritingFeePayable

5126890

usd

CY2023

inaq

Capital Contribution From Sponsor

CapitalContributionFromSponsor

1074015

usd

CY2023

us-gaap

Nature Of Operations

NatureOfOperations

Note 1 - Description of Organization and Business Operations Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. The Company has one subsidiary, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”), a direct wholly owned subsidiary of the Company incorporated in on October 10, 2023. As of December 31, 2023 the subsidiary had no activity. As of December 31, 2023, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through December 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company is unable to complete a Business Combination by June 7, 2024, which may be extended only by the vote of our stockholders to approve an amendment to our amended and restated certificate of incorporation (the “Combination Period”) the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Second Charter Amendment Proposal”), (iii) a proposal to amend the Charter to provide for the right of a holder of Class B common stock of the Company, par value $0.0001 per share (“Class B Common Stock”) to convert such shares into shares of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) on a one-for-one basis prior to the closing of a business combination at the election of the holder (the “Third Charter Amendment Proposal” and together with the First Charter Amendment Proposal and the Second Charter Amendment Proposal, the “Charter Amendment Proposals”) and (iv) a proposal to direct the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve each of the Charter Amendment Proposals. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 remained in the trust account and 2,848,607 shares of Class A Common Stock remained issued and outstanding. On March 28, 2023, the board of directors of the Company approved a one-month extension of the date by which the Company has to consummate a business combination to May 7, 2023 and authorized management to deposit $80,000 into the Trust Account for such extension. Accordingly, management deposited $80,000 into the Trust Account and the date by which the Company has to consummate a business combination has been extended to May 7, 2023. On May 2, 2023, the board of directors of the Company approved an additional one-month extension to June 7, 2023 and deposited an additional $80,000 into the Trust Account. On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase the Company’s Class A Common Stock from holders (other than the Company or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by the Company in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of the Company Class A Common Stock purchased in the Company’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares). On April 3, 2023, the Company entered into a Business Combination Agreement (“Avila BCA”) with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on April 4, 2023. On April 18, 2022, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and that if the Form 10-K is not filed with the SEC by 2:30 p.m. Eastern Time on April 21, 2023, NYSE post the Company to the NYSE’s late filers list on the Profile, Data and News pages with respect to each of the Company’s securities (the “LF Designation”). Effective April 19, 2022, the Company filed the Form 10-K and that same day the Company received additional correspondence from the NYSE acknowledging that the filing had been made and cancelling its prior correspondence and stating that the LF Designation would not be posted on the Profile, Data and News pages with respect to each of the Company’s securities. On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market (“Nasdaq”). In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market. On May 24, 2023, the Company received a notification from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250I(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q’s due date, or until November 20, 2023, to regain compliance. The Company subsequently filed the Form 10-Q for the quarter ended March 31, 2023 on June 2, 2023, regaining compliance. On August 10, 2023, the Company and Avila entered into a Letter Agreement providing for the mutual termination of the Avila BCA. The Letter Agreement provides for the mutual release of claims against the other party and also provides that Avila will pay to the Company $300,000 in partial reimbursement of expenses incurred by the Company in connection with the Avila BCA (the “Avila Payment”). The Avila Payment is due and payable as follows: 1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024. On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note. As approved by its stockholders at the annual meeting of stockholders held on September 6, 2023 (the “Annual Meeting”), the Company filed a Second Amendment (the “Second Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 6, 2023 to modify the terms and extend Combination Period by which the Company has to consummate an initial business combination (the “Business Combination”) from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. On September 7, 2023, October 7, 2023, November 7, 2023, December 15, 2023, January 5, 2024, February 2, 2024, February 7, 2024, March 20, 2024 and May 6, 2024 the Company deposited $20,000 into the Trust Account on each date, to extend the Business Combination Period from September 7, 2023 to June 7, 2024. Effective as of October 13, 2023, the Company, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”) and Alpha Modus, Corp., a Florida corporation (“Alpha Modus”), entered into a business combination agreement and plan of merger (the “AM BCA”) pursuant to which Merger Sub will merge with and into Alpha Modus with Alpha Modus as the surviving corporation and becoming a wholly owned subsidiary of the Company. The Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable the AM BCA, the Merger and the other transactions contemplated thereby (the “Proposed Transactions”). A copy of the AM BCA is filed as Exhibit 2.1 in the Current Report on Form 8-K, dated October 17, 2023. In connection with entering into the AM BCA, in October 2023, the Company formed IAC Merger Sub Inc., a Florida corporation. On December 28, 2023, the Company filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”). The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these consolidated financial statements. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The Company held a meeting on March 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from March 7, 2023, monthly for up to six additional months at the election of the Company, ultimately until as late as September 7, 2023 (the “Extension”, and such extension date the “Extended Date”). In connection with the March 6, 2023 meeting, 21,151,393 shares of the Company’s common stock were redeemed with a total redemption payment of $215,621,387. The Company held its annual meeting on September 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. As a result, the Company booked a liability of $2,348,302 for the excise tax based on 1% of shares redeemed during the reporting period. For interim periods, an entity is not required to estimate future stock repurchases and stock issuances to measure its excise tax obligation. Rather, an entity can generally record the obligation on an as-incurred basis. In other words, the excise tax obligation recognized at the end of a quarterly financial reporting period is calculated as if the end of the quarterly period was the end of the annual period for which the excise tax obligation is payable. Pursuant to the AM BCA, (i) in the event the business combination contemplated by the AM BCA occurs, then the surviving company shall pay the Company’s excise tax liability; (ii) if Alpha Modus does not obtain its shareholders approval of the business combination, or Alpha Modus breaches the AM BCA, then Alpha Modus will be responsible to pay the Company’s excise tax liability; and (iii) if an Alpha Modus material adverse effect occurs and the business combination does not close, or if Alpha Modus fails to close the business combination for any reason other than a material breach by the Company, then Alpha Modus will be responsible to pay the Company’s excise tax liability. In all other circumstances the Company will be responsible to pay the Company’s excise tax liability, except if the Company liquidates prior to December 31, 2023, in which event there will be no excise tax liability. The Company will not use any of the funds held in the Trust Account and any additional amounts deposited into the Trust Account, as well as any interest earned thereon, to pay for the Company’s excise tax liability. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax by the Company have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. In October 2023, the Israel-Hamas war commenced. As a result of the war, instability in the Middle East and various other regions of the world may occur and effect the world economy. Various nations, including the United States, as a reaction to the Israel-Hamas war have begun taking actions that may further affect the world economy. Such effects on the world economy are not determinable as of the date of these consolidated financial statements. The specific impact on the Company’s financial condition, results of operations and cash flows is also not determinable as of the date of these consolidated financial statements. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Liquidity and Going Concern As of December 31, 2023, the Company had approximately $0 in its operating bank account available to pay operating expenses and working capital deficit of approximately $3,571,000. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding under any Working Capital Loans. On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note. On August 30, 2023, the Company, Sponsor and Polar Multi-Strategy Master Fund (“Polar”), an investor, entered into an agreement (the “Subscription Agreement”) in which Polar has agreed to fund the Sponsor up to $1,000,000, pursuant to written draw down requests (a “Capital Call”), and the Sponsor will in turn loan such funds to the Company, to cover the Company’s working capital expenses (each a “Sponsor Loan”). For the year ended December 31, 2023, Polar funded Sponsor $600,000 under the Subscription Agreement and the Sponsor loaned the Company $600,000 from Polar. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until June 7, 2024 (extended monthly through extension payments), to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination by close of business on June 7, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 7, 2024.

CY2023

inaq

Condition For Future Business Combination Number Of Businesses Minimum

ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum

1

pure

CY2023

inaq

Investments Maximum Maturity Term

InvestmentsMaximumMaturityTerm

P185D

CY2023Q4

inaq

Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account

PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount

0.80

pure

CY2023Q4

inaq

Percentage Of Shares Voted

PercentageOfSharesVoted

0.65

pure

CY2023Q1

inaq

Condition For Future Business Combination Threshold Net Tangible Assets

ConditionForFutureBusinessCombinationThresholdNetTangibleAssets

5000001

usd

CY2023

inaq

Avila Payment Description

AvilaPaymentDescription

1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.

CY2023

inaq

Number Of Shares Redemption In Exchange

NumberOfSharesRedemptionInExchange

1847662

shares

CY2023

us-gaap

Stock Redeemed Or Called During Period Value

StockRedeemedOrCalledDuringPeriodValue

19208848

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q4

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q1

us-gaap

Stock Redeemed Or Called During Period Shares

StockRedeemedOrCalledDuringPeriodShares

21151393

shares

CY2023Q1

us-gaap

Stock Redeemed Or Called During Period Value

StockRedeemedOrCalledDuringPeriodValue

215621387

usd

CY2023Q3

inaq

Number Of Shares Redemption In Exchange

NumberOfSharesRedemptionInExchange

1847662

shares

CY2023Q4

us-gaap

Sales And Excise Tax Payable Current

SalesAndExciseTaxPayableCurrent

2348302

usd

CY2023

inaq

Percentage Of Excise Tax Shares Redeemed During The Period

PercentageOfExciseTaxSharesRedeemedDuringThePeriod

0.01

pure

CY2023Q4

inaq

Working Capital Deficit

WorkingCapitalDeficit

3571000

usd

CY2023

us-gaap

Proceeds From Unsecured Notes Payable

ProceedsFromUnsecuredNotesPayable

163000

usd

CY2021Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

157000

usd

CY2021Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

6000

usd

CY2023

us-gaap

Payments For Fees

PaymentsForFees

600000

usd

CY2023

inaq

Sponsor Loan

SponsorLoan

600000

usd

CY2023

us-gaap

Franchisor Costs

FranchisorCosts

2703102

usd

CY2023

us-gaap

Income Taxes Paid

IncomeTaxesPaid

1653743

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2023Q1

us-gaap

Stock Redeemed Or Called During Period Shares

StockRedeemedOrCalledDuringPeriodShares

21151393

shares

CY2023Q1

us-gaap

Stock Redeemed Or Called During Period Value

StockRedeemedOrCalledDuringPeriodValue

215621387

usd

CY2023Q3

inaq

Number Of Shares Redemption In Exchange

NumberOfSharesRedemptionInExchange

1847662

shares

CY2023Q3

us-gaap

Stock Redeemed Or Called During Period Value

StockRedeemedOrCalledDuringPeriodValue

19208848

usd

CY2023Q4

us-gaap

Sales And Excise Tax Payable Current

SalesAndExciseTaxPayableCurrent

2348302

usd

CY2023

inaq

Percentage Of Excise Tax Shares Redeemed During The Period

PercentageOfExciseTaxSharesRedeemedDuringThePeriod

0.01

pure

CY2023Q4

inaq

Working Capital Deficit

WorkingCapitalDeficit

3571000

usd

CY2023

us-gaap

Proceeds From Unsecured Notes Payable

ProceedsFromUnsecuredNotesPayable

163000

usd

CY2021Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

157000

usd

CY2021Q3

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

6000

usd

CY2023

us-gaap

Payments For Fees

PaymentsForFees

600000

usd

CY2023

inaq

Sponsor Loan

SponsorLoan

600000

usd

CY2023

us-gaap

Franchisor Costs

FranchisorCosts

2703102

usd

CY2023

us-gaap

Income Taxes Paid

IncomeTaxesPaid

1653743

usd

CY2023

inaq

Withdrawn From Trust Account And Tax Accured

WithdrawnFromTrustAccountAndTaxAccured

1049359

usd

CY2023Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

628758

usd

CY2023Q3

inaq

Withdrawal Amount

WithdrawalAmount

1049359

usd

CY2023Q3

inaq

Due From Sponsor

DueFromSponsor

994950

usd

CY2023Q4

us-gaap

Restricted Cash

RestrictedCash

314482

usd

CY2023

us-gaap

Concentration Risk Credit Risk

ConcentrationRiskCreditRisk

Concentration of Credit RiskFinancial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

CY2023

inaq

Withdrawn From Trust Account And Tax Accured

WithdrawnFromTrustAccountAndTaxAccured

1049359

usd

CY2023Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

628758

usd

CY2023Q3

inaq

Withdrawal Amount

WithdrawalAmount

1049359

usd

CY2023Q3

inaq

Due From Sponsor

DueFromSponsor

994950

usd

CY2023Q4

us-gaap

Restricted Cash

RestrictedCash

314482

usd

CY2023

us-gaap

Concentration Risk Credit Risk

ConcentrationRiskCreditRisk

Concentration of Credit RiskFinancial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

CY2023Q4

us-gaap

Cash Fdic Insured Amount

CashFDICInsuredAmount

250000

usd

CY2023

us-gaap

Use Of Estimates

UseOfEstimates

Use of EstimatesThe preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

CY2023Q4

us-gaap

Cash Fdic Insured Amount

CashFDICInsuredAmount

250000

usd

CY2023

us-gaap

Use Of Estimates

UseOfEstimates

Use of EstimatesThe preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

CY2023

inaq

Investment Securitie Maturity Period

InvestmentSecuritieMaturityPeriod

P185D

CY2023

inaq

Investment Securitie Maturity Period

InvestmentSecuritieMaturityPeriod

P185D

CY2023Q4

us-gaap

Deferred Tax Liabilities Tax Deferred Income

DeferredTaxLiabilitiesTaxDeferredIncome

600000

usd

CY2023

us-gaap

Amortization Of Financing Costs And Discounts

AmortizationOfFinancingCostsAndDiscounts

279245

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities Tax Deferred Income

DeferredTaxLiabilitiesTaxDeferredIncome

600000

usd

CY2023

us-gaap

Amortization Of Financing Costs And Discounts

AmortizationOfFinancingCostsAndDiscounts

279245

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

156593

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

156593

usd

CY2023

us-gaap

Stockholders Equity Note Stock Split

StockholdersEquityNoteStockSplit

the Company effected a 1:1.1162791 stock split of Class B common stock

CY2023Q4

us-gaap

Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right

ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight

1

shares

CY2023

inaq

Class Of Warrant Or Right Black Out Trading Period After Completion Of Business Combination

ClassOfWarrantOrRightBlackOutTradingPeriodAfterCompletionOfBusinessCombination

P30D

CY2023

us-gaap

Administrative Fees Expense

AdministrativeFeesExpense

180000

usd

CY2022

us-gaap

Administrative Fees Expense

AdministrativeFeesExpense

180000

usd

CY2023Q3

us-gaap

Stock Issued During Period Value Other

StockIssuedDuringPeriodValueOther

480000

usd

CY2023Q3

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

1

CY2023Q4

inaq

Sponsor Advance

SponsorAdvance

420000

usd

CY2023

us-gaap

Related Party Transaction Description Of Transaction

RelatedPartyTransactionDescriptionOfTransaction

On July 20, 2023 and August 7, 2023, a total of $891,000 was transferred to the Sponsor from the operating bank account, of which a total of $616,000 was paid back on October 10, 2023, October 11, 2023 and December 13, 2023. Additionally, during the year ended December 31, 2023 the Sponsor paid operating expenses on behalf of the Company with a total value of $80,000 which has been netted against the amount owed.

CY2023Q1

inaq

Waiver Of Underwriting Commissions

WaiverOfUnderwritingCommissions

5400000

usd

CY2023Q1

inaq

Deferred Underwriting Commissions

DeferredUnderwritingCommissions

8400000

usd

CY2023Q1

inaq

Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable

GainLossOnForgivenessOfDeferredUnderwritingFeesPayable

273110

usd

CY2023Q1

inaq

Reminder Of Deferred Underwriting Commissions

ReminderOfDeferredUnderwritingCommissions

3000000

usd

CY2023Q4

inaq

Deferred Underwriting Commissions Noncurrent

DeferredUnderwritingCommissionsNoncurrent

6600000

usd

CY2022Q4

inaq

Deferred Underwriting Commissions Noncurrent

DeferredUnderwritingCommissionsNoncurrent

12000000

usd

CY2023Q3

inaq

Reimbursement Of Expenses

ReimbursementOfExpenses

300000

usd

CY2023

inaq

Avila Payment Description

AvilaPaymentDescription

1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.

CY2023

us-gaap

Payments For Fees

PaymentsForFees

600000

usd

CY2023

inaq

Sponsor Loaned

SponsorLoaned

325000

usd

CY2023Q4

inaq

Issuance Share

issuanceShare

1

shares

CY2023Q4

us-gaap

Capital Units Outstanding

CapitalUnitsOutstanding

10

shares

CY2023Q3

inaq

Reasonable Attorneys Fees

ReasonableAttorneysFees

5000

usd

CY2023

us-gaap

Stockholders Equity Note Stock Split

StockholdersEquityNoteStockSplit

the Company effected a 1:1.1162791 stock split of Class B common stock

CY2023Q4

us-gaap

Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right

ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight

1

shares

CY2023

inaq

Class Of Warrant Or Right Black Out Trading Period After Completion Of Business Combination

ClassOfWarrantOrRightBlackOutTradingPeriodAfterCompletionOfBusinessCombination

P30D

CY2023

us-gaap

Administrative Fees Expense

AdministrativeFeesExpense

180000

usd

CY2022

us-gaap

Administrative Fees Expense

AdministrativeFeesExpense

180000

usd

CY2023Q3

us-gaap

Stock Issued During Period Value Other

StockIssuedDuringPeriodValueOther

480000

usd

CY2023Q3

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

1

CY2023Q4

inaq

Sponsor Advance

SponsorAdvance

420000

usd

CY2023

us-gaap

Related Party Transaction Description Of Transaction

RelatedPartyTransactionDescriptionOfTransaction

On July 20, 2023 and August 7, 2023, a total of $891,000 was transferred to the Sponsor from the operating bank account, of which a total of $616,000 was paid back on October 10, 2023, October 11, 2023 and December 13, 2023. Additionally, during the year ended December 31, 2023 the Sponsor paid operating expenses on behalf of the Company with a total value of $80,000 which has been netted against the amount owed.

CY2023Q1

inaq

Waiver Of Underwriting Commissions

WaiverOfUnderwritingCommissions

5400000

usd

CY2023Q1

inaq

Deferred Underwriting Commissions

DeferredUnderwritingCommissions

8400000

usd

CY2023Q1

inaq

Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable

GainLossOnForgivenessOfDeferredUnderwritingFeesPayable

273110

usd

CY2023Q1

inaq

Reminder Of Deferred Underwriting Commissions

ReminderOfDeferredUnderwritingCommissions

3000000

usd

CY2023Q4

inaq

Deferred Underwriting Commissions Noncurrent

DeferredUnderwritingCommissionsNoncurrent

6600000

usd

CY2023Q3

inaq

Reimbursement Of Expenses

ReimbursementOfExpenses

300000

usd

CY2023

inaq

Avila Payment Description

AvilaPaymentDescription

1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.

CY2023

inaq

Sponsor Loaned

SponsorLoaned

325000

usd

CY2023Q4

inaq

Issuance Share

issuanceShare

1

shares

CY2023Q4

us-gaap

Capital Units Outstanding

CapitalUnitsOutstanding

10

shares

CY2023Q3

inaq

Reasonable Attorneys Fees

ReasonableAttorneysFees

5000

usd

CY2023Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

1000000

shares

CY2023Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

11.5

CY2023

inaq

Share Redemption Trigger Price

ShareRedemptionTriggerPrice

18

CY2023Q4

inaq

Class Of Warrant Or Right Redemption Price Of Warrants Or Rights

ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights

0.01

CY2023

inaq

Class Of Warrant Or Right Redemption Of Warrants Or Rights

ClassOfWarrantOrRightRedemptionOfWarrantsOrRights

P30D

CY2023

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

762045

usd

CY2023

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-673365

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-85640

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-526707

usd

CY2022

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-242233

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

615387

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

369323

usd

CY2023Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

896030

usd

CY2022Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

369323

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

896030

usd

CY2022Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

369323

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

156593

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities Unrealized Gains On Trading Securities

DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Unrealized Gains On Trading Securities

DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities

156593

usd

CY2023Q4

us-gaap

Tax Credit Carryforward Valuation Allowance

TaxCreditCarryforwardValuationAllowance

896030

usd

CY2022Q4

us-gaap

Tax Credit Carryforward Valuation Allowance

TaxCreditCarryforwardValuationAllowance

369323

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-526707

usd

CY2023Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

1000000

shares

CY2023Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

11.5

CY2023

inaq

Share Redemption Trigger Price

ShareRedemptionTriggerPrice

18

CY2023Q4

inaq

Class Of Warrant Or Right Redemption Price Of Warrants Or Rights

ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights

0.01

CY2023

inaq

Class Of Warrant Or Right Redemption Of Warrants Or Rights

ClassOfWarrantOrRightRedemptionOfWarrantsOrRights

P30D

CY2023

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

762045

usd

CY2022

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

467991

usd

CY2023

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-673365

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-85640

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-526707

usd

CY2022

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-242233

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

615387

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

624584

usd

CY2023Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

896030

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

369323

usd

CY2023Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

896030

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

896030

usd

CY2022Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

369323

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

156593

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities Unrealized Gains On Trading Securities

DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities

9935

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Unrealized Gains On Trading Securities

DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities

156593

usd

CY2023Q4

us-gaap

Tax Credit Carryforward Valuation Allowance

TaxCreditCarryforwardValuationAllowance

896030

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-526707

usd

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2023

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants

0

pure

CY2022

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants

0

pure

CY2023

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants

-3.161

pure

CY2022

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants

-0.179

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-0.507

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

0

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.036

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

pure

CY2023

inaq

Effective Income Tax Rate True Up Startup Organization Costs

EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts

-0.071

pure

CY2022

inaq

Effective Income Tax Rate True Up Startup Organization Costs

EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts

0

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-14.662

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.019

pure

CY2023

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

17.213

pure

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.05

pure

CY2023

us-gaap

Franchisor Costs

FranchisorCosts

2703102

usd

CY2023

us-gaap

Income Taxes Paid

IncomeTaxesPaid

1653743

usd

CY2023

inaq

Withdrawn From Trust Account And Tax Accured

WithdrawnFromTrustAccountAndTaxAccured

1049359

usd

CY2023

us-gaap

Operating Expenses

OperatingExpenses

1415512

usd

CY2023Q2

us-gaap

Operating Expenses

OperatingExpenses

4448

usd

CY2022

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-242233

usd

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2023

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants

0

pure

CY2022

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Transaction Costs Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfTransactionCostsWarrants

0

pure

CY2023

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants

-3.161

pure

CY2022

inaq

Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants

EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants

-0.179

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-0.507

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

0

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.036

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

pure

CY2023

inaq

Effective Income Tax Rate True Up Startup Organization Costs

EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts

-0.071

pure

CY2022

inaq

Effective Income Tax Rate True Up Startup Organization Costs

EffectiveIncomeTaxRateTrueUpStartupOrganizationCosts

0

pure

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-14.662

pure

CY2023

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

17.213

pure

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.05

pure

CY2023

us-gaap

Franchisor Costs

FranchisorCosts

2703102

usd

CY2023

us-gaap

Income Taxes Paid

IncomeTaxesPaid

1653743

usd

CY2023

inaq

Withdrawn From Trust Account And Tax Accured

WithdrawnFromTrustAccountAndTaxAccured

1049359

usd

CY2023

us-gaap

Operating Expenses

OperatingExpenses

1415512

usd

CY2023Q3

us-gaap

Operating Expenses

OperatingExpenses

1411063

usd

CY2023Q3

inaq

Transfer From Operating Account To Sponsor

TransferFromOperatingAccountToSponsor

480000

usd

CY2023Q4

inaq

Sponsor Transferred To The Company

SponsorTransferredToTheCompany

891000

usd

CY2023Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

628758

usd

CY2023Q3

inaq

Withdrawal Amount

WithdrawalAmount

1049359

usd

CY2023Q3

inaq

Due From Sponsor

DueFromSponsor

994950

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

2497250

usd

inaq

Installment Payments

InstallmentPayments

1130000

usd

CY2023Q4

us-gaap

Taxes Payable Current And Noncurrent

TaxesPayableCurrentAndNoncurrent

317900

usd

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

3049360

usd

CY2024Q1

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

1049360

usd

CY2024Q1

inaq

Additional Amount In Trust Account

AdditionalAmountInTrustAccount

36285.07

usd

CY2023

us-gaap

Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense

DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense

132500

usd

CY2023

inaq

Service Fees

ServiceFees

7500

usd

CY2023

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2023

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2023

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2023

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

usd

CY2022Q4

inaq

Excise Tax Payable

ExciseTaxPayable

usd

CY2023Q4

inaq

Franchise Tax Payable

FranchiseTaxPayable

usd

CY2023Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2022Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q4

us-gaap

Preferred Stock Value

PreferredStockValue

usd

CY2023Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2022Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2023Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

usd

CY2022

inaq

Change In Fair Value Of Forward Purchases Agreement Liability

ChangeInFairValueOfForwardPurchasesAgreementLiability

usd

CY2022

us-gaap

Interest Expense Debt

InterestExpenseDebt

usd

CY2022

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

usd

CY2023

us-gaap

Stock Issued During Period Value Conversion Of Convertible Securities

StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

usd

CY2022

us-gaap

Interest Expense Debt

InterestExpenseDebt

usd

CY2022

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

usd

CY2023

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

usd

CY2023Q3

us-gaap

Operating Expenses

OperatingExpenses

1411063

usd

CY2023Q3

inaq

Transfer From Operating Account To Sponsor

TransferFromOperatingAccountToSponsor

480000

usd

CY2023Q3

inaq

Transfer From Operating Account To Sponsor

TransferFromOperatingAccountToSponsor

411000

usd

CY2023Q4

inaq

Sponsor Transferred To The Company

SponsorTransferredToTheCompany

891000

usd

CY2023Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

628758

usd

CY2023Q3

inaq

Withdrawal Amount

WithdrawalAmount

1049359

usd

CY2023Q3

inaq

Due From Sponsor

DueFromSponsor

994950

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

CY2024Q1

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

20000

usd

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

2497250

usd

CY2023Q4

us-gaap

Taxes Payable Current And Noncurrent

TaxesPayableCurrentAndNoncurrent

1447900

usd

inaq

Installment Payments

InstallmentPayments

1130000

usd

CY2023Q4

us-gaap

Taxes Payable Current And Noncurrent

TaxesPayableCurrentAndNoncurrent

317900

usd

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

3049360

usd

CY2024Q1

inaq

Amount Withdrew From Trust Account

AmountWithdrewFromTrustAccount

1049360

usd

CY2024Q1

inaq

Additional Amount In Trust Account

AdditionalAmountInTrustAccount

36285.07

usd

CY2023

us-gaap

Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense

DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense

132500

usd

CY2023

inaq

Service Fees

ServiceFees

7500

usd

CY2023

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2023

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2023

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2023

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

usd

CY2022Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

usd

CY2022Q4

us-gaap

Other Receivables

OtherReceivables

usd

CY2022Q4

inaq

Excise Tax Payable

ExciseTaxPayable

usd

CY2023Q4

inaq

Franchise Tax Payable

FranchiseTaxPayable

usd

CY2023Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2022Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q4

us-gaap

Preferred Stock Value

PreferredStockValue

usd

CY2022Q4

us-gaap

Preferred Stock Value

PreferredStockValue

usd

CY2023Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2022Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2023Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

usd

CY2022

inaq

Change In Fair Value Of Forward Purchases Agreement Liability

ChangeInFairValueOfForwardPurchasesAgreementLiability

usd

CY2022

us-gaap

Interest Expense Debt

InterestExpenseDebt

usd

CY2022

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

usd

CY2023

us-gaap

Stock Issued During Period Value Conversion Of Convertible Securities

StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

usd

CY2022

us-gaap

Interest Expense Debt

InterestExpenseDebt

usd

CY2022

inaq

Gain On Forgiveness Of Deferred Underwriting Fee Payable

GainOnForgivenessOfDeferredUnderwritingFeePayable

usd

CY2022

inaq

Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability

GainLossChangeInFairValueOfForwardPurchaseAgreementLiability

usd

CY2022

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

usd

CY2023

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

usd

CY2022

us-gaap

Increase Decrease In Due To Related Parties

IncreaseDecreaseInDueToRelatedParties

usd

CY2022

inaq

Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption

ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption

usd

CY2022

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

usd

CY2022

us-gaap

Proceeds From Related Party Debt

ProceedsFromRelatedPartyDebt

usd

CY2022

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

usd

CY2022

inaq

Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability

GainLossChangeInFairValueOfForwardPurchaseAgreementLiability

usd

CY2022

inaq

Increase In Due To Investor

IncreaseInDueToInvestor

usd

CY2023

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

usd

CY2022

inaq

Forgiveness Of Deferred Underwriting Fee Payable

ForgivenessOfDeferredUnderwritingFeePayable

usd

CY2022

us-gaap

Increase Decrease In Due To Related Parties

IncreaseDecreaseInDueToRelatedParties

usd

CY2022

inaq

Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption

ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption

usd

CY2022

inaq

Payments For Investment Of Cash In Trust Account

PaymentsForInvestmentOfCashInTrustAccount

usd

CY2022

us-gaap

Proceeds From Related Party Debt

ProceedsFromRelatedPartyDebt

usd

CY2022

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

usd

CY2022

inaq

Increase In Due To Investor

IncreaseInDueToInvestor

usd

CY2023

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

usd

CY2022Q4

us-gaap

Restricted Cash

RestrictedCash

usd

CY2022

inaq

Forgiveness Of Deferred Underwriting Fee Payable

ForgivenessOfDeferredUnderwritingFeePayable

usd

CY2022

inaq

Value Of Excise Tax Liability

ValueOfExciseTaxLiability

usd

CY2022

inaq

Capital Contribution From Sponsor

CapitalContributionFromSponsor

usd

CY2023Q4

us-gaap

Cash Equivalents At Carrying Value

CashEquivalentsAtCarryingValue

usd

CY2023Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

usd

CY2023Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued

usd

CY2023Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2022Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2023Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2023

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

usd

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

usd

CY2023

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

usd

CY2023Q4

inaq

Deferred Tax Asset Startup Or Organization Costs

DeferredTaxAssetStartupOrOrganizationCosts

usd

CY2022Q4

inaq

Deferred Tax Asset Startup Or Organization Costs

DeferredTaxAssetStartupOrOrganizationCosts

usd

CY2023Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

usd

CY2022Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

usd

CY2023

dei

Amendment Flag

AmendmentFlag

false

CY2023

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2023

dei

Entity Central Index Key

EntityCentralIndexKey

0001862463

CY2022

inaq

Value Of Excise Tax Liability

ValueOfExciseTaxLiability

usd

CY2022

inaq

Capital Contribution From Sponsor

CapitalContributionFromSponsor

usd

CY2023Q4

us-gaap

Cash Equivalents At Carrying Value

CashEquivalentsAtCarryingValue

usd

CY2022Q4

us-gaap

Cash Equivalents At Carrying Value

CashEquivalentsAtCarryingValue

usd

CY2023Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

usd

CY2023Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued

usd

CY2023Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2022Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

shares

CY2023Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2022Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

shares

CY2023

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

usd

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

usd

CY2023

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

usd

CY2023Q4

inaq

Deferred Tax Asset Startup Or Organization Costs

DeferredTaxAssetStartupOrOrganizationCosts

usd

CY2022Q4

inaq

Deferred Tax Asset Startup Or Organization Costs

DeferredTaxAssetStartupOrOrganizationCosts

usd

CY2023Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

usd

CY2022Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

usd

CY2023

dei

Amendment Flag

AmendmentFlag

false

CY2023

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2023

dei

Entity Central Index Key

EntityCentralIndexKey

0001862463

Name	View Source	Status
0001213900-24-042933-index-headers.html	Edgar Link	pending
0001213900-24-042933-index.html	Edgar Link	pending
0001213900-24-042933.txt	Edgar Link	pending
0001213900-24-042933-xbrl.zip	Edgar Link	pending
ea0200188-10k_insight.htm	Edgar Link	pending
ea020018801ex10-20_insight.htm	Edgar Link	pending
ea020018801ex31-1_insight.htm	Edgar Link	pending
ea020018801ex31-2_insight.htm	Edgar Link	pending
ea020018801ex32-1_insight.htm	Edgar Link	pending
ea020018801ex32-2_insight.htm	Edgar Link	pending
ea020018801ex97_insight.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inaq-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
inaq-20231231_cal.xml	Edgar Link	unprocessable
inaq-20231231_def.xml	Edgar Link	unprocessable
inaq-20231231_pre.xml	Edgar Link	unprocessable
inaq-20231231_lab.xml	Edgar Link	unprocessable
ea0200188-10k_insight_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod

2023 Q4 Form 10-K Financial Statement

#000121390024042933 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD ALPHA MODUS HOLDINGS, INC. Stock $amod

2023 Q4 Form 10-K Financial Statement

#000121390024042933 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod